Genetics research and biomarker discovery firm Oxford Gene Technology Ltd. (OGT) bought fellow UK-based company Cytocell Technologies Ltd., which offers DNA technology to detect gene rearrangements associated with inherited genetic diseases and cancer. (Mar.)
OGT will fund the acquisition with an undisclosed cash sum as well as a debt facility from Silicon Valley Bank. Founded in 1991, Cytocell develops and manufactures a range of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?